8102
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,215,699) Views
Editor in Chief Professor Garry Walsh
1178-203X
Transdermal buprenorphine in the management of persistent pain – safety aspects
Rudolf Likar
Therapeutics and Clinical Risk Management 2006, 2:115-125
20 January 2006
Percutaneous dermal drug delivery for local pain control
Sujatha Tadicherla, Brian Berman
Therapeutics and Clinical Risk Management 2006, 2:99-113
20 January 2006
Renal cell carcinoma and the use of sorafenib
James MG Larkin, Tim Eisen
Therapeutics and Clinical Risk Management 2006, 2:87-98
20 January 2006
Differences between the bisphosphonates for the prevention and treatment of osteoporosis
Andrew Grey, Ian R Reid
Therapeutics and Clinical Risk Management 2006, 2:77-86
20 January 2006
Telithromycin in the treatment of acute bacterial sinusitis, acute exacerbations of chronic bronchitis, and community-acquired pneumonia
George G Zhanel, Tamiko Hisanaga, Aleksandra Wierzbowski, Daryl J Hoban
Therapeutics and Clinical Risk Management 2006, 2:59-75
20 January 2006
Etoricoxib for arthritis and pain management
Peter Brooks, Paul Kubler
Therapeutics and Clinical Risk Management 2006, 2:45-57
20 January 2006
Anti-hepatitis C virus therapy in liver transplanted patients
Antonino Picciotto
Therapeutics and Clinical Risk Management 2006, 2:39-44
20 January 2006
Ciclesonide for the treatment of asthma
Ronald Dahl
Therapeutics and Clinical Risk Management 2006, 2:25-37
20 January 2006
Oxybutynin: an overview of the available formulations
Rebecca J McCrery, Rodney A Appell
Therapeutics and Clinical Risk Management 2006, 2:19-24
20 January 2006
Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
Frieder Bauss and Ralph C Schimmer
Therapeutics and Clinical Risk Management 2006, 2:3-18
20 January 2006
Editorial ||FREE PAPER||
Garry Walsh
Therapeutics and Clinical Risk Management 2006, 2:1-2
12 May 2006
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
